Meyka Pro banner
Rockwell Medical, Inc.

Rockwell Medical, Inc. (RMTI) Stock Overview

Explore Rockwell Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RMTINASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$7.35
$0.27(3.81%)
U.S. Market is Open · 13:57

Rockwell Medical, Inc. (RMTI)

Meyka AI Score

Z

Key Financials

Market Cap30.8M
P/E Ratio-5.04
EPS (TTM)$-1.05
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$8.27
3 Months$7.01
1 Year Target$1.17

RMTI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Rockwell Medical, Inc. (NASDAQ: RMTI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Rockwell Medical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RMTI on the NASDAQ shows an RSI of 75.08, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $1.17 for the NASDAQ listing.

Key metrics behind Rockwell Medical, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.04 and a market capitalization of 30.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RMTI on the NASDAQ.

Price Performance (NASDAQ: RMTI)

1-Day Change
10.04%
5-Day Change
8.81%
1-Month Change
38.88%
3-Month Change
-7.58%
6-Month Change
-23.62%
Year-to-Date (YTD) Change
-6.58%
1-Year Change
-19.76%
3-Year Change
-72.66%
5-Year Change
-89.27%
All-Time (Max) Change
-98.62%

Contact Information

248 960 9009
30142 South Wixom road, Wixom, MI, 48393

Company Facts

1,570 Employees
IPO DateJan 27, 1998
CountryUS
Actively Trading

Frequently Asked Questions